0000904454-13-000770.txt : 20130702 0000904454-13-000770.hdr.sgml : 20130702 20130702170036 ACCESSION NUMBER: 0000904454-13-000770 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130701 FILED AS OF DATE: 20130702 DATE AS OF CHANGE: 20130702 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Esperion Therapeutics, Inc. CENTRAL INDEX KEY: 0001434868 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 46701 COMMERCE CENTER DRIVE CITY: PLYMOUTH STATE: MI ZIP: 48170 BUSINESS PHONE: 734-862-4840 MAIL ADDRESS: STREET 1: 46701 COMMERCE CENTER DRIVE CITY: PLYMOUTH STATE: MI ZIP: 48170 FORMER COMPANY: FORMER CONFORMED NAME: HDL THERAPEUTICS INC DATE OF NAME CHANGE: 20080513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DP VII ASSOCIATES LP CENTRAL INDEX KEY: 0001372932 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35986 FILM NUMBER: 13949518 BUSINESS ADDRESS: STREET 1: ONE PALMER SQ STREET 2: STE 515 CITY: PRINCETON STATE: NJ ZIP: 08542 MAIL ADDRESS: STREET 1: ONE PALMER SQ STREET 2: STE 515 CITY: PRINCETON STATE: NJ ZIP: 08542 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-07-01 0001434868 Esperion Therapeutics, Inc. ESPR 0001372932 DP VII ASSOCIATES LP C/O DOMAIN ASSOCIATES, LLC ONE PALMER SQUARE PRINCETON NJ 08542 0 0 1 0 Common Stock 2013-07-01 4 C 0 30462 A 30462 D Common Stock 2013-07-01 4 P 0 4791 14.00 A 35253 D Series A Preferred Stock 2013-07-01 4 C 0 30462 0 D Common Stock 30462 0 D Warrant to Purchase Series A Preferred Stock 1.00 2013-07-01 4 J 0 8346 0 D Series A Preferred Stock 8346 0 D Warrant to Purchase Common Stock 6.99 2013-07-01 4 J 0 1193 0 A 2018-02-12 Common Stock 1193 1193 D All outstanding shares of Series A Preferred Stock were automatically converted into Common Stock upon the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. Upon the closing of the IPO the Warrants to purchase Series A Preferred Stock automatically converted on a 6.986-for-1 basis into Warrants to purchase Common Stock, and the exercise price automatically adjusted to $6.99 per share, pursuant to the terms of such Warrants. This transaction is reported on Form 4 solely for the purpose of reflecting such changes. The Warrant is immediately exercisable. /s/Kathleen K. Schoemaker, Managing Member of One Palmer Square Associates VII, LLC, General Partner of DP VII Associates, L.P. 2013-07-02